Radiopharmaceutical therapy (RPT) offers molecular-targeted treatment strategies and presents an ideal model for advancing ...

Background Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality with limited therapeutic options. Despite ...

A new study redefines obesity, potentially classifying nearly 70% of US adults as obese, a significant jump from previous ...

Abstract: Safe motion control in unknown environments is one of the challenging tasks in robotics, such as autonomous navigation. Control Barrier Function (CBF), as a strong math-ematical tool, has ...

Are you preparing for UPSC CSE 2026 Prelims? Check your progress and revise your topics through this quiz on Polity and ...

Khaberni - Artificial intelligence is no longer just a tool for writing messages or summarizing documents, but by 2025 it has ...

List making is ultimately a forward, affirmative act — the wish to impose order on a chaotic world. In that spirit, we ...

Based Detection, Linguistic Biomarkers, Machine Learning, Explainable AI, Cognitive Decline Monitoring Share and Cite: de Filippis, R. and Al Foysal, A. (2025) Early Alzheimer’s Disease Detection from ...

Learn more about whether Lantheus Holdings, Inc. or Omnicell, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Omeros to Host Conference Call Monday, December 29, 2025 at 4:30 p.m. ET -- -- First and only approved option: YARTEMLEA(R) is the only approved treatment for hematopoietic stem cell ...

Omeros Corporation (NASDAQ: OMER) today announced that the U.S. Food and Drug Administration (FDA) has approved YARTEMLEA® ...